MERLIN: hoMEcare aRm rehabiLItatio
- Conditions
- Stroke1002830210007963cerebrovasculair accident10014523
- Registration Number
- NL-OMON48182
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 15
unilateral paresis, first incidence of stroke, minimal 6 months, maximum 3
years post stroke, Fugl-Meyer Assessment-Upper extremity score below 50, able
to perform 3 times finger extension and have some proximal voluntary movement
capability, ability to give informed consent, visual and cognitive ability to
participate in the protocol, understand dutch or english language, know how to
operate a computer (of someone to help)
(Self-reported) depression, other rheumatologic, orthopaedic or neurological
disorders,
following occupational or physiotherapy specifically focussed on the arm/hand
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main study outcome is the Wolf Motor Function Test (WMFT). This wil be<br /><br>tested six weeks before the intervention (T0), just before the start of the<br /><br>intervention (T1) and after the six weeks of intervention (T2). To examine the<br /><br>retention, these tests will be performed again six weeks after the end of the<br /><br>intervention (T3) and after 6 months (T4).</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary outcomes are the Action Research Arm Test (ARAT), Fugl-Meyer<br /><br>Assessment-Upper Extermity (FMA-UE), Intrinsic Motivation Inventory (IMI),<br /><br>System Usability Scale (SUS), Dutch Quebec User Evaluation of Satisfaction with<br /><br>Assistive Technology (D-QUEST) and EuroQol-5D (EQ-5D) and biomechanical data<br /><br>using the ArmAssist Assessment (AAA). Subjective opinion will be assessed<br /><br>during in-depth interviews. </p><br>